Friedenreich, CM; Neilson, HK, Lynch, BM. State of the epidemiological evidence on physical activity and cancer prevention. European journal of cancer (Oxford, England : 1990). September 2010, 46 (14): 2593–2604. PMID 20843488. doi:10.1016/j.ejca.2010.07.028.引文使用过时参数coauthors (帮助)
Yamazawa, K; Shimada, H; Hirai, M; Hirashiki, K; Ochiai, T; Ishikura, H; Shozu, M; Isaka, K. Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer. American journal of obstetrics and gynecology. 2007, 197 (5): 505–7. PMID 17980190. doi:10.1016/j.ajog.2007.04.033.
Chong, I; Hoskin, PJ. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer. Brachytherapy. 2008, 7 (2): 195–9. PMID 18358790. doi:10.1016/j.brachy.2008.01.001.
Santin AD, Bellone S, Roman JJ, McKenney JK, Pecorelli S. Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu. Int J Gynaecol Obstet. 2008, 102 (2): 128–131. PMID 18555254. doi:10.1016/j.ijgo.2008.04.008.
Nicolaije KA, Ezendam NP, Vos MC, Boll D, Pijnenborg JM, Kruitwagen RF, et al. Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry. Gynecologic Oncology. May 2013, 129 (2): 324–331. PMID 23435365. doi:10.1016/j.ygyno.2013.02.018.
Di Cristofano, Antonio; Ellenson, Lora Hedrick. Endometrial Carcinoma. Annual Review of Pathology: Mechanisms of Disease. February 2007, 2 (1): 57–85. doi:10.1146/annurev.pathol.2.010506.091905.引文使用过时参数coauthors (帮助)
figo.org
FIGO's updated Cancer Report 2018. Cancer of the corpus uteri. The International Federation of Gynecology and Obstetrics (FIGO).
Koskas M, Amant F, Mirza MR, Creutzberg CL. Cancer of the corpus uteri: 2021 update. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):45-60. doi: 10.1002/ijgo.13866. PMID 34669196; PMCID: PMC9297903.
Goodman, ET; et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res. 1997, 57 (22): 5077–85. PMID 9371506.引文使用过时参数coauthors (帮助)
Friedenreich, CM; Neilson, HK, Lynch, BM. State of the epidemiological evidence on physical activity and cancer prevention. European journal of cancer (Oxford, England : 1990). September 2010, 46 (14): 2593–2604. PMID 20843488. doi:10.1016/j.ejca.2010.07.028.引文使用过时参数coauthors (帮助)
Yamazawa, K; Shimada, H; Hirai, M; Hirashiki, K; Ochiai, T; Ishikura, H; Shozu, M; Isaka, K. Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer. American journal of obstetrics and gynecology. 2007, 197 (5): 505–7. PMID 17980190. doi:10.1016/j.ajog.2007.04.033.
Chong, I; Hoskin, PJ. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer. Brachytherapy. 2008, 7 (2): 195–9. PMID 18358790. doi:10.1016/j.brachy.2008.01.001.
Santin AD, Bellone S, Roman JJ, McKenney JK, Pecorelli S. Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu. Int J Gynaecol Obstet. 2008, 102 (2): 128–131. PMID 18555254. doi:10.1016/j.ijgo.2008.04.008.
Nicolaije KA, Ezendam NP, Vos MC, Boll D, Pijnenborg JM, Kruitwagen RF, et al. Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry. Gynecologic Oncology. May 2013, 129 (2): 324–331. PMID 23435365. doi:10.1016/j.ygyno.2013.02.018.
Oldenburg C.S. et al. The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based PROFILES registry. Gynecologic Oncology, 129 (1), April 2013, page 216–21, PMID 23296262 (页面存档备份,存于互联网档案馆).
Ezendam N.P. et al. Health Care Use Among Endometrial Cancer Survivors: A Study From PROFILES, a Population-Based Survivorship Registry. International Journal of Gynecological Cancer, Epub ahead of print, July 22, 2013, PMID 23881102 (页面存档备份,存于互联网档案馆).
Nicolaije K.A. et al. Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry, Patient education and counseling, 88(3), Sep 2012, page 427–35, PMID 22658248 (页面存档备份,存于互联网档案馆)
Van de Poll-Franse L.V. et al. The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. Trials, 5 (12). 2011 Dec, page 256, PMID 22141750 (页面存档备份,存于互联网档案馆)
Oldenburg C.S. et al. The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based PROFILES registry. Gynecologic Oncology, 129 (1), April 2013, page 216–21, PMID 23296262 (页面存档备份,存于互联网档案馆).
Ezendam N.P. et al. Health Care Use Among Endometrial Cancer Survivors: A Study From PROFILES, a Population-Based Survivorship Registry. International Journal of Gynecological Cancer, Epub ahead of print, July 22, 2013, PMID 23881102 (页面存档备份,存于互联网档案馆).
Nicolaije K.A. et al. Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry, Patient education and counseling, 88(3), Sep 2012, page 427–35, PMID 22658248 (页面存档备份,存于互联网档案馆)
Van de Poll-Franse L.V. et al. The impact of a cancer Survivorship Care Plan on gynecological cancer patient and health care provider reported outcomes (ROGY Care): study protocol for a pragmatic cluster randomized controlled trial. Trials, 5 (12). 2011 Dec, page 256, PMID 22141750 (页面存档备份,存于互联网档案馆)